Form 8-K - Current report:
SEC Accession No. 0001213900-25-036785
Filing Date
2025-04-29
Accepted
2025-04-29 16:00:31
Documents
13
Period of Report
2025-04-25
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0239699-8k_pluri.htm   iXBRL 8-K 25162
  Complete submission text file 0001213900-25-036785.txt   198852

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE plur-20250425.xsd EX-101.SCH 3029
3 XBRL LABEL FILE plur-20250425_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE plur-20250425_pre.xml EX-101.PRE 22368
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0239699-8k_pluri_htm.xml XML 3696
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
Pluri Inc. (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 25886940
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)